How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway-Reference-Cited by-同舟云学术

How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway

Published:2023-10-04 Issue: Volume: Page:
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU International

Author:

Ptasznik Gideon¹²³^ORCID,Kelly Brian D.¹⁴,Murphy Declan¹^ORCID,Lawrentschuk Nathan¹^ORCID,Kasivisvanathan Veeru¹⁵^ORCID,Page Mark⁶,Ong Sean¹^ORCID,Moon Daniel⁴⁷^ORCID

Affiliation:

1. Division of Cancer Surgery Peter MacCallum Cancer Centre Melbourne VIC Australia

2. School of Public Health and Preventive Medicine Monash University Melbourne VIC Australia

3. Young Urology Research Organisation Melbourne VIC Australia

4. Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne VIC Australia

5. Division of Surgery and Interventional Science University College London London UK

6. Division of Medical Imaging St. Vincents Hospital (Melbourne Victoria) Melbourne VIC Australia

7. Royal Melbourne Hospital Clinical School University of Melbourne Melbourne VIC Australia

Publisher

Wiley

Subject

Urology

Reference6 articles.

1. The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study

2. The Benefits of Risk Assessment Tools for Prostate Cancer

3. Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators

4. A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy

5. A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy